Results 191 to 200 of about 26,553 (248)

Universal off-the-shelf combination immunotherapy using oncolytic viruses to redirect T cell engagers to target solid tumors. [PDF]

J Immunother Cancer
Park AK, Monroy I, Ren Y, Lu C, Chaurasiya S, Valencia H, Lent-Koop J, Cook C, Kang S, Lopez L, Murad JP, Yamaguchi Y, Urak R, Chang WC, Shah M, Chong LMO, Fong Y, Forman SJ, Wang X, Priceman SJ.   +19 more
europepmc   +1 more source

Nanoengineering-armed oncolytic viruses drive antitumor response: progress and challenges. [PDF]

MedComm (2020)
Zhang Y, Shi X, Shen Y, Dong X, He R, Chen G, Zhang Y, Tan H, Zhang K.   +8 more
europepmc   +1 more source

Oncolytic viruses: a potential breakthrough immunotherapy for multiple myeloma patients. [PDF]

Front Immunol
Raimondi V, Vescovini R, Dessena M, Donofrio G, Storti P, Giuliani N.   +5 more
europepmc   +1 more source

Mission impossible: mesenchymal stem cells delivering oncolytic viruses before self-destruction. [PDF]

Mol Ther Oncol
Li JX, Wong JC.
europepmc   +1 more source

Extracellular matrix re-normalization to improve cold tumor penetration by oncolytic viruses. [PDF]

Front Immunol
Soko GF, Kosgei BK, Meena SS, Ng YJ, Liang H, Zhang B, Liu Q, Xu T, Hou X, Han RPS.   +9 more
europepmc   +1 more source

Strategies for engineering oncolytic viruses to enhance cancer immunotherapy. [PDF]

Front Pharmacol
Yin ZS, Wang Z.
europepmc   +1 more source

Characterisation and Sensitivity of a Canine Mast Cell Tumour Line to Oncolytic Viruses. [PDF]

Vet Comp Oncol
Mehrani Y, Kakish JE, Napoleoni C, Thompson JJ, Knapp JP, Minott JA, Yates JGE, Stuart D, Coomber BL, Foster RA, Bridle BW, Karimi K.   +11 more
europepmc   +1 more source

The investigation of oncolytic viruses in the field of cancer therapy. [PDF]

Front Oncol
Yuan Z, Zhang Y, Wang X, Wang X, Ren S, He X, Su J, Zheng A, Guo S, Chen Y, Deng S, Wu X, Li M, Du F, Zhao Y, Shen J, Wang Z, Xiao Z.   +17 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Oncolytic viruses

Nature Reviews Cancer, 2002
Although the cytotoxic effects of viruses are usually viewed in terms of pathogenicity, it is possible to harness this activity for therapeutic purposes. Viral genomes are highly versatile, and can be modified to direct their cytotoxicity towards cancer cells. These viruses are known as oncolytic viruses.
Lynda K. Hawkins, David Kirn
exaly   +5 more sources